[des-Arg10]kallidin (Human) [2839]
[des-Arg10]kallidin (Human)
| SMILES | NCCCC[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](Cc1ccccc1)C(=O)N[C@@H](CO)C(=O)N1CCC[C@H]1C(=O)N[C@@H](Cc1ccccc1)C(=O)O |
| InChIKey | AILVBOHFGXNHCC-TZPCGENMSA-N |
| Sequence | KRPPGFSPF |
| HELM | PEPTIDE1{K.R.P.P.G.F.S.P.F}$$$$ |
Chemical Properties
| Hydrogen bond acceptors | 13 |
| Hydrogen bond donors | 11 |
| Rotatable bonds | 27 |
| Log P | -2.913 |
| Molecular weight (Da) | 1031.6 |
| Stereochemistry info | unspecified |
Database connections
| Structure pdb | 7EIB |
Bioactivities
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
| Receptor | Activity | Source | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Protein | Gene | Species | Family | Class | Type | Min | Avg | Max | Database |
[des-Arg10]kallidin (Human)
Drug properties
| Molecular type | Peptide |
| Physiological/Surrogate | Endogenous |
| Approved drug | No |
Distribution across phases (no. indications)
Phase I
0
Phase II
0
Phase III
0
Phase IV
0
Database connections
| Structure pdb | 7EIB |